1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with lysophosphatidylcholines in 206 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (lysophosphatidylcholines) | Trials (lysophosphatidylcholines) | Recent Studies (post-2010) (lysophosphatidylcholines) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 5,058 | 39 | 976 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 138 (66.99) | 18.7374 |
| 1990's | 36 (17.48) | 18.2507 |
| 2000's | 20 (9.71) | 29.6817 |
| 2010's | 9 (4.37) | 24.3611 |
| 2020's | 3 (1.46) | 2.80 |
| Authors | Studies |
|---|---|
| Benveniste, J; Bidault, J; Boullet, C; Polonsky, J; Tencé, M; Varenne, P | 1 |
| Gómez-Fernández, JC; Soler, F; Teruel, JA | 1 |
| Kulikov, VI; Muzia, GI | 1 |
| Gereliuk, IP; Stukal, IV | 1 |
| Filep, JG; Földes-Filep, E; Hermán, F; Kelemen, E | 1 |
| Bihler, I; Choy, PC; Kinnaird, AA; Man, RY | 1 |
| Dadan, J; Macconi, D; Nanni, V; Noris, M; Perico, N; Peterlongo, F; Remuzzi, G | 1 |
| Filep, J; Földes-Filep, E | 1 |
| Bauer, JA; Conzen, P; Fritz, H; Wurster, K | 1 |
| Northover, AM | 1 |
| Kamata, K; Kasuya, Y; Mori, T; Shigenobu, K | 1 |
| Bereziat, G; Chachaty, C; Oliver, JL; Wolf, C | 1 |
| Ferber, E; Munder, PG; Storch, J | 1 |
| Benveniste, J; Dulioust, A; Metezeau, P; Praseuth, D; Salem, P; Thomas, Y; Vivier, E | 1 |
| Bitter-Suermann, D; Englberger, W; Hadding, U | 1 |
| Clay, KL; Haroldsen, PE; Murphy, RC | 1 |
| Altin, JG; Bygrave, FL; Dieter, P | 1 |
| Parthasarathy, S; Quinn, MT; Steinberg, D | 1 |
| Bratton, DL; Clay, KL; Harris, RA; Henson, PM | 1 |
| Billah, MM; Egan, RW; Pai, JK; Siegel, MI | 1 |
| Hoffman, DR; Hoffman, LH; Snyder, F | 1 |
| Kertscher, HP; Lang, A; Ostermann, G; Till, U | 1 |
| Cordeiro, RS; Henriques, MG; Martins, MA; Silva, PM; Vargaftig, BB | 1 |
| Nakaya, H; Tohse, N | 1 |
| Vigo, C | 1 |
| Chap, H; Douste-Blazy, L | 1 |
| Authi, KS; Crawford, N; McKean, ML; Silver, MJ | 1 |
| Ferber, E; Herrmann, DB; Munder, PG | 1 |
| Kertscher, HP; Ostermann, G; Till, U | 1 |
| Fink, KL; Gross, RW | 1 |
| Gerrard, JM | 1 |
| Benveniste, J; Hadji, L; Mencia-Huerta, JM | 1 |
| Benveniste, J; Mencia-Huerta, JM; Roubin, R | 1 |
| Benveniste, J; Bussolino, F | 1 |
| Aglietta, M; Bussolino, F; Camussi, G; Coda, R; Piacibello, W; Tetta, C | 1 |
| Sanchez-Vizcaino, JM; Slauson, DO | 1 |
| Fiedel, BA; O'Donnell, MC | 1 |
| Benveniste, J | 1 |
| Haslam, RJ; Vanderwel, M | 1 |
| Donlon, MA; Kaliner, M; Metcalfe, DD | 1 |
| Bussolino, F; Camussi, G | 1 |
| Renooij, W; Snyder, F | 1 |
| Benveniste, J; Mencia-Huerta, JM | 1 |
| Ferrigni, KS; Hanahan, DJ; McManus, LM; Pinckard, RN; Shaw, JO | 1 |
| Lees, CJ; McCall, CE; O'Flaherty, JT; Swendsen, CL | 1 |
| Lees, CJ; McCall, CE; O'Flaherty, JT; Shewmake, T; Thomas, MJ; Wykle, RL | 1 |
| Hammett, MJ; Love, SH; McCall, CE; O'Flaherty, JT; Shewmake, TB; Thomas, MJ; Wykle, RL | 1 |
| Alonso, F; Mato, JM; Sánchez-Crespo, M | 1 |
| Baehner, RL; Boxer, LA; Yasaka, T | 1 |
| Allen, JM; Baehner, RL; Boxer, LA; Coates, TD; Higgins, CP; Ingraham, LM | 1 |
| Ayer, DE; Gorman, RR; Miller, OV | 1 |
| Coles, E; Goetzl, EJ; Reinhold, VR; Valone, FH | 1 |
| Hanahan, DJ; Shukla, SD | 1 |
| Benveniste, J; Mencia-Huerta, JM; Ninio, E | 1 |
| Broekman, MJ; Kaplan, KL; Marcus, AJ; Safier, LB; Ullman, HL; Weksler, BB; Wong, KT | 1 |
| Deguchi, K; Murashima, S; Shirakawa, S | 1 |
| Andreesen, R; Costabel, U; Löhr, GW; Luckenbach, GA; Munder, PG; Osterholz, J; Schulz, A; Speth, V | 1 |
| Fukuzawa, K; Harada, K; Tokumura, A; Tsukatani, H | 1 |
| Benveniste, J; Boullet, C; Misumi, J; Pirotzky, E | 1 |
| Benveniste, J; Chignard, M; Le Couedic, JP; Vargaftig, BB | 3 |
| Arnoux, B; Benveniste, J; Duval, D | 1 |
| Blank, ML; Lee, TC; Malone, B; Snyder, F | 1 |
| Lyons, RM; Shaw, JO | 1 |
| Ferreira, SH; Vargaftig, BB | 1 |
| Chilton, FH; DeChatelet, LR; O'Flaherty, JT; Thomas, MJ; Waite, BM; Walsh, CE; Wykle, RL | 1 |
| Henson, PM | 1 |
| Arnoux, B; Benveniste, J; Durand, J; Rigaud, M; Vargaftig, BB | 1 |
| Beck, EA; Furlan, M; Perret, BA | 1 |
| Bowman, BJ; Smith, RJ | 1 |
| Chignard, M; Lefort, J; Vargaftig, BB; Wal, F | 1 |
| Benveniste, J; Landes, A; Mencia-Huerta, JM; Roubin, R | 1 |
| Burrell, R; Gee, JB; Morgan, WK; Vesterlund, J; Willoughby, WF | 1 |
| Fitzgerald, V; Lee, TC; Malone, B; Snyder, F; Wasserman, SI | 1 |
| Benveniste, J; Das, BC; Lunel, J; Polonsky, J; Tencé, M; Varenne, P | 1 |
| Betz, SJ; Henson, PM | 1 |
| Bussolino, F; Camussi, G; Ghezzo, F; Pegoraro, L | 1 |
| Bender, N; Breddin, K; Kirchmaier, CM; Sayegh, AA | 1 |
| Bloor, CM; Hugli, TE; McCall, CE; O'Flaherty, JT; Stimler, NP; Wykle, RL | 1 |
| Henson, PM; Shaw, JO | 1 |
| Benveniste, J; Chignard, M; Lefort, J; Vargaftig, BB | 2 |
| Clark, PO; Demopoulos, CA; Halonen, M; Hanahan, DJ; Kniker, WT; McManus, LM; Pinckard, RN; Shaw, JO | 1 |
| Benveniste, J; Chignard, M; Vargaftig, BB | 1 |
| Colwell, JA | 1 |
| Soter, NA; Wintroub, BU | 1 |
| Benveniste, J; Chignard, M; Lefort, J; Vargaftig, BB; Wal, F | 1 |
| Arnoux, B; Benveniste, J; Jouvin, E; Mencia-Huerta, JM; Pirotzky, E; Roubin, R; Vargaftig, BB | 1 |
| Byers, LW; Chesney, CM; Muirhead, EE; Pifer, DD | 1 |
| Benveniste, J; Czarnetzki, BM | 2 |
| Bussolino, F; Camussi, G; Chiara Deregibus, M; Segoloni, G; Tetta, C | 1 |
| Kumahara, Y; Masugi, F; Ogihara, T; Otsuka, A; Saeki, S | 1 |
| Lapetina, EG | 1 |
| Morley, J; Page, CP; Paul, W | 1 |
| Benveniste, J; Mencia-Huerta, JM; Ninio, E; Roubin, R | 1 |
| Bussolino, F; Camussi, G; Deregibus, MC; Segoloni, G; Tetta, C; Vercellone, A | 1 |
| Benveniste, J; Heymans, F; Mencia-Huerta, JM; Ninio, E | 1 |
| Ebbe, S; Long, MW; Williams, N | 1 |
| Hanahan, DJ; Humphrey, DM; McManus, LM; Pinckard, RN; Satouchi, K | 1 |
| Gimbrone, MA | 1 |
| High, JA; Namm, DH; Tadepalli, AS | 1 |
| Benveniste, J; Keraly, CL | 1 |
| O'Flaherty, JT; Piantadosi, C; Salzer, WL; Surles, JR; Wykle, RL | 1 |
| Alonso, F; Alvarez, V; Egido, J; Iñarrea, P; Sánchez-Crespo, M | 1 |
| Benveniste, J; Mencia-Huerta, JM; Morgat, JL; Roubin, R | 1 |
| Mueller, HW; O'Flaherty, JT; Wykle, RL | 1 |
| Basran, GS; Morley, J; Page, CP; Paul, W | 1 |
| Aglietta, M; Bussolino, F; Camussi, G; Piacibello, W; Segoloni, G; Tetta, C | 1 |
| Barton, M; Lefort, J; Prancan, A; Vargaftig, BB | 1 |
| Hanahan, DJ; Humphrey, DM; Pinckard, RN | 1 |
| Hanahan, DJ; McManus, LM; Pinckard, RN | 1 |
| High, JA; Namm, DH | 1 |
| Hanahan, DJ; Klusick, SJ; Shaw, JO | 1 |
| Hanahan, DJ; McManus, LM; Pinckard, RN; Satouchi, K | 1 |
| Bass, DA; DeChatelet, LR; Lewis, JC; McCall, CE; Miller, CH; O'Flaherty, JT; Waite, M; Wykle, RL | 2 |
| Hanahan, DJ; McManus, L; Munder, PG; Pinckard, RN; Satouchi, K | 1 |
| Cox, CP; Farr, RS; Jorgensen, R; Wardlow, ML | 2 |
| Fiedel, BA; O'Donnell, MC; Siegel, JN | 1 |
| Findlay, SR; Hanahan, DJ; Lichtenstein, LM; Pinckard, RN | 1 |
| Demopoulos, CA; Kapoulas, VM; Tsabikakis, GE | 1 |
| Halonen, M; Lohman, IC; McManus, LM; Palmer, JD; Pinckard, RN | 2 |
| Lewis, JC; Miller, CH; O'Flaherty, JT; Piantadosi, C; Schmitt, JD; Smith, JA; Surles, JR; Wykle, RL | 1 |
| Crawford, MH; Fitzpatrick, FA; Hanahan, DJ; McManus, LM; O'Rourke, RA; Pinckard, RN | 1 |
| Blank, ML; Cress, EA; Snyder, F; Whittle, T | 1 |
| Hanahan, DJ; Pinckard, RN; Satouchi, K | 1 |
| Alonso, F; Gil, MG; Mato, JM; Sánchez-Crespo, M | 1 |
| Benveniste, J; Borrel, MC; Coeffier, E; Convert, O; Godfroid, JJ; Heymans, F; Michel, E; Tence, M; Wichrowski, B | 1 |
| Halonen, M; Hanahan, DJ; McManus, LM; Pinckard, RN | 1 |
| Czarnetzki, BM; Muramatsu, T | 1 |
| Bessin, P; Bonnet, J; Loiseau, AM; Orvoen, M | 1 |
| Arnoux, B; Benveniste, J; Denjean, A; Lockhart, A; Masse, R | 1 |
| Clark, PO; Hanahan, DJ; Pinckard, RN | 1 |
| Demopoulos, CA; Hanahan, DJ; McManus, LM; Pinckard, RN | 1 |
| Cusack, NJ | 1 |
| Demopoulos, CA; Hanahan, DJ; Liehr, J; Pinckard, RN | 1 |
| Benveniste, J; Godfroid, JJ; Heymans, F; Michel, E; Redeuilh, C; Steiner, E | 1 |
| Benveniste, J; Chap, H; Douste-Blazy, L; Mauco, G; Simon, MF | 1 |
| Buckalew, VM; Handa, RK; Strandhoy, JW | 1 |
| Mégraud, F | 1 |
| Frenkel, RA; Johnston, JM; Narahara, H; Toyoshima, K | 1 |
| Inoue, S; Miyahara, K; Nishi, M; Noda, N; Tanaka, R | 1 |
| Hemmings, R; Langlais, J; Lepage, N; Miron, P; Roberts, KD | 1 |
| Henry, PD; Kerns, SA; Kugiyama, K; Mangin, EL; Nguy, JH | 1 |
| Amirkhanian, JD; Taeusch, HW | 1 |
| Benveniste, J; el Azzouzi, B; Jurgens, P; Thomas, Y | 1 |
| Bourque, J; Bouzayen, R; Jarvi, K; Lachapelle, MH; Langlais, J; Miron, P | 1 |
| Barnes, PJ; Chung, KF; Elwood, W; Sakamoto, T | 1 |
| Gagnon, C; Jarvi, K; Langlais, J; Roberts, KD | 1 |
| Calligerou, M; Galanopoulou, D; Mavri-Vavayanni, M; Siafaka-Kapadai, A; Weintraub, ST | 1 |
| Das, AK; Hajra, AK | 1 |
| Anderson, R; Ramafi, G; Theron, AJ | 1 |
| Jarvis, WD; Spangelo, BL | 1 |
| Camussi, G; Lupia, E; Montrucchio, G; Savu, SR; Silvestro, L; Sörgel, F | 1 |
| Fukao, M; Hattori, Y; Kanno, M; Kitabatake, A; Sakuma, I | 1 |
| Anderson, R; Feldman, C; Theron, AJ | 1 |
| Adimoolam, S; Glenn, K; Jonas, A; Lee, YP; Liu, M; Subbaiah, PV | 1 |
| Cheglakov, IB; Korotaeva, AA; Morozkin, AD; Prokazova, NV; Suslova, IV | 1 |
| Ares, M; Cercek, B; Dahlgren, B; Hultgårdh Nilsson, A; Nilsson, J; Shah, PK; Westman, J | 1 |
| Chang, H; Roy Baker, R | 1 |
| Baker, RR; Chang, H | 1 |
| Fukuzawa, K; Nishioka, Y; Shinomiya, J; Tokumura, A; Yoshimoto, O | 1 |
| Claesson, HE; Frostegård, J; Huang, YH; Schäfer-Elinder, L; Wu, R | 1 |
| Goldman, R; Moshonov, S; Zor, U | 2 |
| Akiyama, M; Goyal, J; Liu, M; Miwa, M; Subbaiah, PV; Subramanian, VS; Sugatami, J | 1 |
| Fuentes, E; McNaughton, PA; Nadal, A | 1 |
| Hong, J; Im, KS; Jung, JH; Kim, YR; Lee, IS; Shin, BA; Sim, CJ; Sung, CK | 1 |
| Asai, Y; Iwamoto, K; Murahashi, N; Nomura, T | 1 |
| Hayakawa, J; Ishida, M; Taguchi, R; Takeuchi, Y | 1 |
| Aiboshi, J; Ciesla, DJ; Moore, EE; Silliman, CC | 1 |
| Chapman, MJ; Hourton, D; Ninio, E; Stengel, D | 1 |
| Anderson, R; Cole, PJ; Feldman, C; Steel, HC; Theron, AJ; van Rensburg, CE; Wilson, R | 1 |
| de Castro Faria Neto, HC; Marathe, GK; McIntyre, TM; Prescott, SM; Silva, AR; Tjoelker, LW; Zimmerman, GA | 1 |
| Macphee, CH | 1 |
| Hanada, K; Hara, T; Horii, T; Kurokawa, K; Magistrado, PA; Mitamura, T; Nishijima, M; Palacpac, NM; Rai, G; Sakata, D | 1 |
| Anderson, R; Cockeran, R; Steel, HC | 1 |
| Biffl, WL; Carnaggio, R; Ciesla, DJ; Johnson, JL; Moore, EE; Silliman, CC | 1 |
| Bremme, K; Frostegård, J; Wramsby, ML; Wu, R | 1 |
| Fukuzawa, K; Kogure, K; Nakashima, S; Tokumura, A; Tsuchie, A | 1 |
| Fujii, S; Ikeda, K; Ikezawa, H; Morita, M; Sakurai, S; Tsukamoto, K; Yoshida, A | 1 |
| Owen, JS; Samuel, MP; Thomas, MJ; Wykle, RL | 1 |
| Gao, XP; Lin, P; Malik, AB; Welch, EJ; Ye, RD | 1 |
| Damaj, BB; Jin, Y; Maghazachi, AA | 1 |
| Deussen, A; Pexa, A | 1 |
| Aoyama, C; Aso, C; Izumi, T; Mori, M; Sugimoto, H; Sugimoto, S | 1 |
| Benveniste, MJ; Le Couedic, JP; Polonsky, J; Tencé, V | 1 |
| Bennett, SA; Ethier, M; Figeys, D; Hou, W; Smith, JC; Whitehead, SN | 1 |
| Cheng, L; Han, X; Shi, Y | 1 |
| Allende, M; Cerveró, J; Esmon, CT; Hermida, J; López-Sagaseta, J; Montes, R; Puy, C; Tamayo, I; Velasco, SE | 1 |
| Baker, DL; Parrill, AL; Pham, TC; Wanjala, IW | 1 |
| Bennett, SA; Fai, S; Figeys, D; Valenzuela, N; Xu, H | 1 |
| Ajandouz, el H; Bouza, B; Fontbonne, H; Lombardo, D; Puigserver, A | 1 |
| Back, SH; Kim, SJ; Koh, JM; Yoo, HJ | 1 |
| Almeida, IC; Gazos-Lopes, F; Gomes, MT; Hoelz, LV; Lopes, AH; Marques, AF; Monteiro, RQ; Nakayasu, ES; Oliveira, MM; Pascutti, PG; Salloum, NG; Souto-Padrón, T; Vieira, DP | 1 |
| Berger, J; Dorninger, F; Fischer, P; Forss-Petter, S; Gleiss, A; Hinterberger, M; Jungwirth, S; Kou, J; Moser, AB; Wiesinger, C | 1 |
| Abhilasha, KV; Chaithra, VH; Chen, CH; Jacob, SP; Kemparaju, K; Lakshmikanth, CL; Marathe, GK; McIntyre, TM; Sahu, RP; Sumanth, MS; Thyagarajan, A; Travers, JB | 1 |
| Li, Y; Liang, L; Tian, X; Zhong, L; Zhou, J | 1 |
| Barnes, GN; Cai, J; Chu, T; Kong, M; Shields, CB; Shields, LBE; Tian, Z; Wang, Y; Zhang, YP; Zhu, Q | 1 |
| Ebina, K; Sakurai, E; Sato, A; Watanabe, H; Yamazaki, M | 1 |
| Cabanelas, A; Coelho, FS; Fragoso, SP; Gonçalves, IC; Lopes, AH; Martins-Duarte, ES; Moreira, ICF; Oliveira, MM; Pascutti, PG; Torres, PHM; Vieira, DP | 1 |
14 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and lysophosphatidylcholines
| Article | Year |
|---|---|
[Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].
Topics: Azepines; Diterpenes; Fibrinolytic Agents; Ginkgolides; Humans; In Vitro Techniques; Lactones; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Function Tests; Thrombosis; Triazoles | 1991 |
Phospholipid metabolism and cell stimulus activation coupling in platelets and other blood cells.
Topics: Actins; Arachidonic Acid; Arachidonic Acids; Biological Evolution; Biological Transport; Blood Cells; Blood Platelets; Blood Vessels; Calcium; Cell Membrane; Diglycerides; Endoplasmic Reticulum; Hydrolysis; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Lipid Bilayers; Lipids; Lysophosphatidylcholines; Lysophospholipids; Myosins; Organoids; Phosphatidic Acids; Phosphatidylcholines; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositols; Phospholipases A; Phospholipids; Platelet Activating Factor; Solubility; Type C Phospholipases; Water | 1984 |
Platelet-activating factor (PAF-acether): present status.
Topics: Animals; Blood Coagulation Factors; Histamine Release; Humans; In Vitro Techniques; Lysophosphatidylcholines; Molecular Conformation; Platelet Activating Factor | 1981 |
The mast cell.
Topics: Animals; Autacoids; Calcium; Cattle; Chemotactic Factors; Cytoplasmic Granules; Cytoskeleton; Dogs; Energy Metabolism; Esterases; Guinea Pigs; Heparin; Histamine Release; Humans; Hypersensitivity, Immediate; Lipid Metabolism; Lysophosphatidylcholines; Lysosomes; Mast Cells; Mice; Microtubules; Nucleotides, Cyclic; Platelet Activating Factor; Prostaglandins; Rabbits; Rats; Receptors, IgE; Receptors, Immunologic; Serotonin; Thromboxanes | 1981 |
[Blood platelet aggregation].
Topics: Arachidonic Acids; Calcium; Glycoproteins; Humans; Lysophosphatidylcholines; Membrane Proteins; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Thrombocythemia, Essential; Thrombocytopenia | 1981 |
Molecular pathobiology of acetyl glyceryl ether phosphorylcholine: evidence for the structural and functional identity with platelet-activating factor.
Topics: Animals; Blood Platelets; Chemical Phenomena; Chemistry; Humans; Hypersensitivity; Inflammation; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Factor 4; Serotonin | 1980 |
Present concepts on the mechanisms of platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Carrageenan; Crotalid Venoms; Humans; Lectins, C-Type; Lysophosphatidylcholines; Membrane Lipids; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Thromboxanes; Type C Phospholipases | 1981 |
Studies on the pathogenesis of diabetic vascular disease.
Topics: Diabetes Mellitus; Diabetic Angiopathies; Endothelium; Humans; Lipids; Lipoproteins; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Prostaglandins | 1981 |
Biology of the mast cell and its role in cutaneous inflammation.
Topics: Animals; Bone Marrow Cells; Chemotactic Factors; Chemotactic Factors, Eosinophil; Cytoplasmic Granules; Dermatitis; Histamine; Humans; Interleukin-8; Lysophosphatidylcholines; Mast Cells; Mitosis; Muscle Contraction; Muscle, Smooth; Nucleotides, Cyclic; Platelet Activating Factor; Proteoglycans; Rats; SRS-A | 1981 |
Background and present status of research on platelet-activating factor (PAF-acether).
Topics: Animals; Basophils; Blood Platelets; Chromatography, Thin Layer; Dogs; Guinea Pigs; Humans; Leukocytes; Lipase; Lysophosphatidylcholines; Macrophages; Neutrophils; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Sulfinpyrazone | 1981 |
Platelet-activating factor (PAF-acether): molecular aspects of its release and pharmacological actions.
Topics: Animals; Basophils; Blood Platelets; Humans; Kidney; Leukocytes; Lung; Lysophosphatidylcholines; Mast Cells; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1981 |
Toxic factors of Helicobacter pylori.
Topics: Acetaldehyde; Bacterial Toxins; Cytotoxins; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Hemolysin Proteins; Humans; Lysophosphatidylcholines; Platelet Activating Factor; Stomach Diseases | 1994 |
Lipoprotein-associated phospholipase A2: a potential new risk factor for coronary artery disease and a therapeutic target.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Biomarkers; Coronary Artery Disease; Enzyme Inhibitors; Fatty Acids, Nonesterified; Humans; Infections; Inflammation; Lipoproteins, LDL; Lysophosphatidylcholines; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Risk Factors | 2001 |
Targeted lipidomics - advances in profiling lysophosphocholine and platelet-activating factor second messengers.
Topics: Humans; Lipid Metabolism; Lysophosphatidylcholines; Mass Spectrometry; Membrane Lipids; Metabolome; Metabolomics; Platelet Activating Factor; Second Messenger Systems | 2013 |
192 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and lysophosphatidylcholines
| Article | Year |
|---|---|
[Semi-synthesis and proposed structure of platelet-activating factor (P.A.F.): PAF-acether an alkyl ether analog of lysophosphatidylcholine].
Topics: Acetylation; Animals; Lysophosphatidylcholines; Methods; Methylation; Plasmalogens; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1979 |
On the effect of lysophosphatidylcholine, platelet activating factor and other surfactants on calcium permeability in sarcoplasmic reticulum vesicles.
Topics: Animals; Calcium; Kinetics; Lysophosphatidylcholines; Micelles; Muscles; Platelet Activating Factor; Rabbits; Sarcoplasmic Reticulum; Surface-Active Agents | 1991 |
[Disorders of plasma lipid spectrum, lysoform levels of platelet activating factor and blood platelet sensitivity to adrenaline in patients with stable stress-induced stenocardia].
Topics: Adult; Angina Pectoris; Blood Platelets; Epinephrine; Humans; Hypercholesterolemia; In Vitro Techniques; Lipids; Lysophosphatidylcholines; Male; Middle Aged; Platelet Activating Factor; Psychophysiologic Disorders; Stress, Psychological | 1991 |
C-reactive protein inhibits binding of platelet-activating factor to human platelets.
Topics: Antibody Formation; Blood Platelets; C-Reactive Protein; Humans; L-Lactate Dehydrogenase; Lysophosphatidylcholines; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Binding | 1991 |
The association of lysophosphatidylcholine with isolated cardiac myocytes.
Topics: Animals; Calcium; Glycerylphosphorylcholine; Lidocaine; Lysophosphatidylcholines; Male; Myocardium; Palmitic Acid; Palmitic Acids; Platelet Activating Factor; Rats; Rats, Inbred Strains; Sarcolemma; Temperature | 1990 |
Renal metabolism and urinary excretion of platelet-activating factor in the rat.
Topics: Animals; Chromatography, High Pressure Liquid; Doxorubicin; Glycerol; Kidney; Kidney Glomerulus; Kidney Tubules, Proximal; Kinetics; Lysophosphatidylcholines; Nephrosis; Phospholipids; Platelet Activating Factor; Proteinuria; Rats; Rats, Inbred Strains; Serum Albumin, Bovine; Tritium | 1990 |
Effects of C-reactive protein on human neutrophil granulocytes challenged with N-formyl-methionyl-leucyl-phenylalanine and platelet-activating factor.
Topics: C-Reactive Protein; Cell Membrane; Cytoplasmic Granules; Dose-Response Relationship, Drug; Humans; Kinetics; Lysophosphatidylcholines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Superoxides | 1989 |
Modulation of resynthesis of 1-alkyl-2-arachidonyl-glycero-3-phosphocholine and phosphatidylinositols for interception in vivo of free arachidonic acid, lyso-PAF, diacyl-glycerols, and phosphoinositides.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Burns; Diglycerides; Disease Models, Animal; Flavonoids; Ginkgo biloba; Hemostatics; Humans; Lysophosphatidylcholines; Pain; Pain Measurement; Phosphatidylinositols; Plant Extracts; Platelet Activating Factor; Swine | 1989 |
Effects of PAF and PAF antagonists on the shape of venous endothelial cells in vitro.
Topics: Animals; Calcimycin; Diterpenes; Electron Spin Resonance Spectroscopy; Endothelium, Vascular; Furans; Ginkgolides; Guinea Pigs; Lactones; Leukotriene E4; Lysophosphatidylcholines; Phospholipid Ethers; Platelet Activating Factor; SRS-A; Vena Cava, Inferior | 1989 |
Platelet-activating factor: lack of direct action on guinea pig myocardium and possible transmitter release from cardiac sympathetic nerve endings at high concentrations.
Topics: Action Potentials; Animals; Electrophysiology; Guinea Pigs; Heart; In Vitro Techniques; Isoproterenol; Lysophosphatidylcholines; Male; Myocardium; Neurons; Neurotransmitter Agents; Papillary Muscles; Platelet Activating Factor; Reserpine; Sotalol; Sympathetic Nervous System | 1989 |
Effect of PAF acether on oriented egg phosphatidylcholine multibilayers; interaction with cholesterol; comparison to lyso-PC and lyso-PAF.
Topics: Animals; Chickens; Cholesterol; Lipid Bilayers; Lysophosphatidylcholines; Ovum; Phosphatidylcholines; Platelet Activating Factor | 1989 |
Influence of platelet activating factor and a nonmetabolizable analogue on superoxide production by bone marrow derived macrophages.
Topics: Bone Marrow Cells; Humans; Luminescent Measurements; Lysophosphatidylcholines; Macrophages; Platelet Activating Factor; Protein Kinase C; Superoxides; Tetradecanoylphorbol Acetate | 1988 |
Immunoregulatory functions of paf-acether. II. Decrease of CD2 and CD3 antigen expression.
Topics: Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Carrier Proteins; CD2 Antigens; CD3 Complex; Concanavalin A; Depression, Chemical; Gene Expression Regulation; Humans; Lymphocyte Activation; Lysophosphatidylcholines; Phytohemagglutinins; Platelet Activating Factor; Receptors, Immunologic; T-Lymphocytes; Tumor Cells, Cultured | 1988 |
Influence of lysophospholipids and PAF on the oxidative burst of PMNL.
Topics: Acetophenones; Animals; Complement C5; Complement C5a; Female; Guinea Pigs; In Vitro Techniques; Luminescent Measurements; Lysophosphatidylcholines; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1987 |
Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry.
Topics: Calcimycin; Chromatography, Thin Layer; Gas Chromatography-Mass Spectrometry; Humans; Lysophosphatidylcholines; Mass Spectrometry; Neutrophils; Platelet Activating Factor | 1987 |
Evidence that Ca2+ fluxes and respiratory, glycogenolytic and vasoconstrictive effects induced by the action of platelet-activating factor and L-alpha-lysophosphatidylcholine in the perfused rat liver are mediated by products of the cyclo-oxygenase pathwa
Topics: Acetophenones; Animals; Calcium; Dose-Response Relationship, Drug; Indomethacin; Liver; Liver Glycogen; Lysophosphatidylcholines; Male; Oxygen Consumption; Perfusion; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred Strains | 1987 |
Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.
Topics: Animals; Arteriosclerosis; Chemotaxis, Leukocyte; Foam Cells; Humans; In Vitro Techniques; Lysophosphatidylcholines; Macrophages; Monocytes; Oxidation-Reduction; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rabbits; Structure-Activity Relationship | 1988 |
Effects of platelet activating factor and related lipids on phase transition of dipalmitoylphosphatidylcholine.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Calorimetry, Differential Scanning; Chemical Phenomena; Chemistry, Physical; Fluorescence Polarization; Lysophosphatidylcholines; Platelet Activating Factor; Structure-Activity Relationship; Thermodynamics | 1988 |
Activation of phospholipase D by chemotactic peptide in HL-60 granulocytes.
Topics: Diglycerides; Enzyme Activation; Ethanol; Glycerophospholipids; Granulocytes; Humans; Kinetics; Leukemia, Myeloid; Lysophosphatidylcholines; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Phosphates; Phosphatidic Acids; Phospholipase D; Phospholipases; Phospholipid Ethers; Platelet Activating Factor; Tumor Cells, Cultured | 1988 |
Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Membrane; Dogs; Humans; Lysophosphatidylcholines; Microsomes, Liver; Mixed Function Oxygenases; Phospholipid Ethers; Platelet Activating Factor; Rats; Substrate Specificity | 1986 |
Stimulation and desensitization of human and rabbit platelets by 1-O-hexadecyl-2-O-methyl-rac-glycero-3-phosphocholine and analogues.
Topics: Animals; Blood Platelets; Humans; Isomerism; Lysophosphatidylcholines; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Rabbits; Structure-Activity Relationship | 1986 |
Platelet involvement in rat paw edema induced by 2-methoxy-PAF.
Topics: Animals; Blood Platelets; Edema; Female; Lysophosphatidylcholines; Male; Phospholipid Ethers; Platelet Activating Factor; Rabbits; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Electrophysiological effects of acetyl glyceryl ether phosphorylcholine on cardiac tissues: comparison with lysophosphatidylcholine and long chain acyl carnitine.
Topics: Action Potentials; Animals; Carnitine; Dogs; Female; Heart; In Vitro Techniques; Lysophosphatidylcholines; Male; Membrane Potentials; Myocardial Contraction; Papillary Muscles; Platelet Activating Factor; Purkinje Fibers | 1986 |
Effect of C-reactive protein on platelet-activating factor-induced platelet aggregation and membrane stabilization.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; C-Reactive Protein; Cell Membrane; Lysophosphatidylcholines; Phospholipases; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thrombin | 1985 |
[Cell membrane and phospholipids].
Topics: Arachidonic Acid; Arachidonic Acids; Blood Platelets; Calcium; Cell Membrane; Humans; Lysophosphatidylcholines; Membrane Lipids; Phospholipases A; Phospholipases A2; Phospholipids; Platelet Activating Factor; Prostaglandins; SRS-A; Thromboxanes; Type C Phospholipases | 1985 |
Formation of diacyl- and alkylacylphosphatidylcholine by the membranes of human platelets.
Topics: Acyltransferases; Blood Platelets; Cell Membrane; Humans; Intracellular Membranes; Lysophosphatidylcholines; Phosphatidylcholines; Platelet Activating Factor | 1986 |
Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Acyl Coenzyme A; Acylation; Acyltransferases; Animals; Dose-Response Relationship, Drug; Female; Kinetics; Lysophosphatidylcholines; Macrophages; Mice; Phospholipid Ethers; Phospholipids; Platelet Activating Factor | 1986 |
Platelet-stimulating and membranolytic properties of racemic PAF-acether and analogues.
Topics: Blood Platelets; Cell Membrane; Humans; In Vitro Techniques; Lysophosphatidylcholines; Phospholipids; Platelet Activating Factor; Platelet Aggregation; Serotonin | 1985 |
Modulation of canine myocardial sarcolemmal membrane fluidity by amphiphilic compounds.
Topics: Animals; Dogs; Electron Spin Resonance Spectroscopy; Hydrogen-Ion Concentration; In Vitro Techniques; Lysophosphatidylcholines; Membrane Fluidity; Membrane Lipids; Myocardium; Phospholipases A; Phospholipases A2; Phospholipids; Platelet Activating Factor; Sarcolemma; Surface-Active Agents | 1984 |
Release of a slow-reacting substance from rabbit platelets.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Adenosine Diphosphate; Animals; Arachidonic Acids; Aspirin; Autacoids; Blood Platelets; Chromatography, High Pressure Liquid; Cysteine; Indomethacin; Kinetics; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thrombin | 1981 |
Release of platelet-activating factor (PAF-acether) and leukotrienes C and D from inflammatory macrophages.
Topics: Animals; Autacoids; Chromatography, High Pressure Liquid; Female; Inflammation; Lysophosphatidylcholines; Macrophages; Mice; Mice, Inbred C57BL; Platelet Activating Factor; SRS-A | 1982 |
Pharmacological modulation of platelet-activating factor (PAF) release from rabbit leucocytes. I. Role of cAMP.
Topics: Anaphylaxis; Animals; Antigens; Basophils; Blood Platelets; Bucladesine; Cyclic AMP; Dose-Response Relationship, Immunologic; Female; Histamine Release; Isoproterenol; Leukocytes; Lysophosphatidylcholines; Male; Platelet Activating Factor; Platelet Aggregation; Rabbits; Theophylline | 1980 |
Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils.
Topics: Antigen-Antibody Complex; Basophils; Blood Coagulation Factors; Blood Platelets; Calcimycin; Cytoplasmic Granules; Histamine Release; Humans; In Vitro Techniques; Leukocytes; Lysophosphatidylcholines; Microscopy, Electron; Monocytes; Neutrophils; Phagocytosis; Platelet Activating Factor; Platelet Aggregation | 1981 |
Leukocyte-dependent platelet vasoactive amine release and immune complex deposition in African swine fever.
Topics: African Swine Fever; Animals; Antibodies, Viral; Antigen-Antibody Complex; Blood Platelets; Complement System Proteins; Epitopes; Leukocytes; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Serotonin; Swine | 1981 |
Histamine secretion from human leucocytes stimulated by basophil-derived platelet-activating factor.
Topics: Basophils; Blood Coagulation Factors; Chromatography, Thin Layer; Histamine Release; Humans; Leukocytes; Lymphocyte Activation; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation | 1981 |
Inhibition of platelet adenylate cyclase by 1-O-alkyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor).
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Diphosphate; Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Alprostadil; Animals; Blood Platelets; Creatine Kinase; Cyclic AMP; Indomethacin; Lysophosphatidylcholines; Phosphocreatine; Platelet Activating Factor; Prostaglandins E; Rabbits | 1982 |
Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
Topics: Adenosine Diphosphate; Animals; Aorta; Blood Platelets; Bucladesine; Epoprostenol; Isoproterenol; Kinetics; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Prostaglandins; Prostaglandins, Synthetic; Rabbits; Serotonin; Theophylline | 1980 |
Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues.
Topics: Animals; Antihypertensive Agents; Blood Platelets; Cytosol; Diacylglycerol Cholinephosphotransferase; Diglycerides; Lysophosphatidylcholines; Male; Microsomes; Microsomes, Liver; Phosphotransferases; Platelet Activating Factor; Rats; Spleen; Substrate Specificity | 1981 |
Platelet-activating factor (PAF-acether) and macrophages. II. Phagocytosis-associated release of PAF-acether from rat peritoneal macrophages.
Topics: Animals; Antigen-Antibody Complex; Ascitic Fluid; Bordetella pertussis; Colchicine; Cytochalasin B; Endocytosis; Erythrocytes; Female; Lysophosphatidylcholines; Macrophages; Male; Microspheres; Phagocytosis; Platelet Activating Factor; Rats; Zymosan | 1981 |
Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycerol-3-phosphorylcholine (platelet activating factor).
Topics: Animals; Cell Aggregation; Cell Movement; Cytochalasin B; Humans; Lysophosphatidylcholines; Lysosomes; Neutrophils; Platelet Activating Factor; Rabbits; Superoxides | 1981 |
Role of extracellular calcium and neutrophil degranulation responses to 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine.
Topics: Animals; Calcium; Calcium Channel Blockers; Cytochalasin B; Extracellular Space; Glucuronidase; Ion Channels; Kinetics; Lysophosphatidylcholines; Lysosomes; Magnesium; Neutrophils; Platelet Activating Factor; Rabbits; Verapamil | 1981 |
Neutrophil-degranulating action of 5,12-dihydroxy-6,8,10,14-eicosatetraenoic acid and 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine. Comparison with other degranulating agents.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcimycin; Calcium; Cattle; Chemotactic Factors; Cytochalasin B; Cytoplasmic Granules; Humans; In Vitro Techniques; Leukotriene B4; Lysophosphatidylcholines; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Platelet Activating Factor; Rabbits; Stimulation, Chemical; Tetradecanoylphorbol Acetate | 1981 |
Evidence for 5, 12-dihydroxy-6,8,10,14-eicosatetraenoate as a mediator of human neutrophil aggregation.
Topics: Arachidonic Acids; Calcimycin; Cell Aggregation; Chemotaxis, Leukocyte; Complement C5; Complement C5a; Humans; Kinetics; Leukotriene B4; Lysophosphatidylcholines; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Platelet Activating Factor; Tetradecanoylphorbol Acetate | 1981 |
Modulatory role of cyclic AMP in the release of platelet-activating factor from human polymorphonuclear leucocytes.
Topics: Blood Coagulation Factors; Blood Platelets; Cyclic AMP; Cyclic GMP; Epinephrine; Glucuronidase; Humans; Isoproterenol; Lysophosphatidylcholines; Phosphodiesterase Inhibitors; Pilocarpine; Platelet Activating Factor; Platelet Aggregation; Zymosan | 1982 |
Monocyte aggregation and superoxide anion release in response to formyl-methionyl-leucyl-phenylalanine (FMLP) and platelet-activating factor (PAF).
Topics: Calcium; Cell Aggregation; Cytochalasin B; Deoxyglucose; Humans; Iodoacetates; Iodoacetic Acid; Lysophosphatidylcholines; Magnesium; Methionine; Monocytes; Muramidase; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Oxygen; Platelet Activating Factor; Superoxides | 1982 |
Metabolic, membrane, and functional responses of human polymorphonuclear leukocytes to platelet-activating factor.
Topics: Cell Adhesion; Cell Aggregation; Cell Membrane; Chemotaxis, Leukocyte; Humans; Lysophosphatidylcholines; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Oxygen Consumption; Platelet Activating Factor; Platelet Aggregation; Superoxides | 1982 |
Acetyl glycerylphosphorylcholine inhibition of prostaglandin I2-stimulated adenosine 3',5'-cyclic monophosphate levels in human platelets. Evidence for thromboxane A2 dependence.
Topics: Blood Platelets; Cyclic AMP; Dose-Response Relationship, Drug; Epoprostenol; Humans; Indomethacin; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Prostaglandins; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1982 |
Specific binding of phospholipid platelet-activating factor by human platelets.
Topics: Blood Platelets; Cell Membrane; Humans; Kinetics; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Receptors, Cell Surface | 1982 |
AGEPC (platelet activating factor) induced stimulation of rabbit platelets: effects on phosphatidylinositol, di- and triphosphoinositides and phosphatidic acid metabolism.
Topics: Animals; Blood Platelets; In Vitro Techniques; Lysophosphatidylcholines; Phosphatidic Acids; Phosphatidylinositols; Phospholipids; Phosphorus; Platelet Activating Factor; Rabbits; Stimulation, Chemical | 1982 |
Biosynthesis of platelet-activating factor (PAF-acether). V. Enhancement of acetyltransferase activity in murine peritoneal cells by calcium ionophore A23187.
Topics: Acetyltransferases; Animals; Anti-Bacterial Agents; Ascitic Fluid; Calcimycin; Enzyme Activation; In Vitro Techniques; Lysophosphatidylcholines; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains | 1983 |
Effects of acetyl glyceryl ether phosphorylcholine on human platelet function in vitro.
Topics: Adenosine Diphosphate; Apyrase; beta-Thromboglobulin; Blood Platelets; Calcium; Creatine Kinase; Drug Synergism; Humans; Lysophosphatidylcholines; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Serotonin; Thromboxane A2 | 1981 |
Tumor cytotoxicity of human macrophages after incubation with synthetic analogues of 2-lysophosphatidylcholine.
Topics: Antineoplastic Agents; Cell Line; Cytotoxicity, Immunologic; Humans; In Vitro Techniques; Lymphoma; Lysophosphatidylcholines; Macrophage Activation; Macrophages; Phospholipid Ethers; Platelet Activating Factor | 1984 |
Biphasic action of platelet-activating factor on isolated guinea-pig ileum.
Topics: Animals; Guinea Pigs; Ileum; Lysophosphatidylcholines; Male; Muscle Contraction; Platelet Activating Factor | 1983 |
[Release of platelet activating factor (P.A.F.-acether) by isolated perfused rat kidney].
Topics: Animals; Calcimycin; Hypersensitivity, Immediate; Kidney; Kinetics; Leukocytes; Lysophosphatidylcholines; Male; Perfusion; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats | 1980 |
Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Blood Coagulation Factors; Blood Platelets; Calcimycin; Collagen; In Vitro Techniques; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thrombin; Time Factors | 1980 |
One, two, three or more pathways for platelet aggregation.
Topics: Acetophenones; Adenosine Diphosphate; Arachidonic Acids; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Humans; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Thrombin; Thromboxane A2 | 1980 |
Release of platelet-activating factor (PAF-acether) from alveolar macrophages by the calcium ionophore A23187 and phagocytosis.
Topics: Animals; Anti-Bacterial Agents; Blood Platelets; Calcimycin; Calcium; Humans; Lysophosphatidylcholines; Macrophages; Phagocytosis; Platelet Activating Factor; Platelet Aggregation; Pulmonary Alveoli; Rabbits; Rats | 1980 |
1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor) stimulates calcium influx in rabbit platelets.
Topics: Animals; Blood Platelets; Calcium; Edetic Acid; Female; Lysophosphatidylcholines; Male; Platelet Activating Factor; Rabbits; Time Factors | 1981 |
Requirements for different Ca2+ pools in the activation of rabbit platelets. I. release reaction and protein phosphorylation.
Topics: Animals; Blood Platelets; Blood Proteins; Calcimycin; Calcium; Gallic Acid; Lysophosphatidylcholines; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serotonin; Thrombin; Time Factors | 1982 |
Blockade of the inflammatory effects of platelet-activating factor by cyclo-oxygenase inhibitors.
Topics: Animals; Aspirin; Carrageenan; Cyclooxygenase Inhibitors; Edema; Hyperalgesia; Indomethacin; Lysophosphatidylcholines; Platelet Activating Factor; Rats | 1981 |
Platelet activating factor. Stimulation of the lipoxygenase pathway in polymorphonuclear leukocytes by 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Coagulation Factors; Calcimycin; Cattle; Cytochalasin B; Glucuronidase; Kinetics; Lipoxygenase; Lysophosphatidylcholines; Muramidase; Myocardium; Neutrophils; Platelet Activating Factor; Rabbits | 1982 |
Biosynthesis of platelet-activating factor (PAF-ACETHER). II. Involvement of phospholipase A2 in the formation of PAF-ACETHER and lyso-PAF-ACETHER from rabbit platelets.
Topics: Acetophenones; Animals; Blood Platelets; Calcimycin; Edetic Acid; Egtazic Acid; Kinetics; Lysophosphatidylcholines; Phospholipases; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rabbits; Thrombin | 1982 |
Platelet-activating factor (PAF) as a mediator of neutrophil-platelet interactions in inflammation.
Topics: Arachidonic Acid; Arachidonic Acids; Basophils; Blood Coagulation Factors; Blood Platelets; Humans; Immunoglobulin E; In Vitro Techniques; Inflammation; Lysophosphatidylcholines; Neutrophils; Platelet Activating Factor | 1981 |
Release of platelet-activating factor (PAF-acether) and arachidonic acid metabolites from alveolar macrophages.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcimycin; Humans; In Vitro Techniques; Inflammation; Lysophosphatidylcholines; Macrophages; Papio; Platelet Activating Factor; Pulmonary Alveoli; Rats | 1981 |
Binding of bovine factor VIII-coated colloidal gold particles to receptors on platelet membranes.
Topics: Animals; Binding Sites; Blood Platelets; Cattle; Cell Membrane; Colloids; Factor VIII; Gold; Humans; In Vitro Techniques; Lysophosphatidylcholines; Membrane Proteins; Platelet Activating Factor; Protein Binding | 1981 |
Stimulation of human neutrophil degranulation with 1-O-octadecyl-2-O-acetyl-SN-glyceryl-3-phosphorylcholine: modulation by inhibitors of arachidonic acid metabolism.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Calcium; Catechols; Cyclooxygenase Inhibitors; Cytochalasin B; Cytoplasmic Granules; Humans; Lipoxygenase Inhibitors; Lysophosphatidylcholines; Masoprocol; Muramidase; Neutrophils; Platelet Activating Factor | 1982 |
Inhibition by sulphinpyrazone of the platelet-dependent bronchoconstriction due to platelet-activating factor (PAF-acether) in the guinea pig.
Topics: Adenosine Diphosphate; Airway Resistance; Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Bronchi; Guinea Pigs; In Vitro Techniques; Lysophosphatidylcholines; Muscle Contraction; Platelet Activating Factor; Platelet Count; Sulfinpyrazone | 1982 |
Biosynthesis of platelet-activating factor (PAF-acether). IV. Impairment of acetyl-transferase activity in thioglycollate-elicited mouse macrophages.
Topics: Acetyl Coenzyme A; Acetyltransferases; Animals; Calcimycin; Female; Lysophosphatidylcholines; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Thioglycolates; Zymosan | 1982 |
Byssinosis: some unanswered questions.
Topics: Arachidonic Acid; Arachidonic Acids; Byssinosis; Forced Expiratory Volume; Histamine; Humans; Lysophosphatidylcholines; Platelet Activating Factor; SRS-A | 1982 |
Activities of enzymes that metabolize platelet-activating factor (1-Alkyl-2-acetyl-sn-glycero-3-phosphocholine) in neutrophils and eosinophils from humans and the effect of a calcium ionophore.
Topics: Acetyltransferases; Alkyl and Aryl Transferases; Anti-Bacterial Agents; Calcimycin; Carboxylic Ester Hydrolases; Eosinophils; Humans; Kinetics; Lysophosphatidylcholines; Neutrophils; Platelet Activating Factor; Transferases | 1982 |
Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids.
Topics: Leukocytes; Lysophosphatidylcholines; Mass Spectrometry; Platelet Activating Factor; Platelet Aggregation; Structure-Activity Relationship | 1980 |
Neutrophil and platelet interactions in "allergic" and inflammatory reactions: a role for acetyl glyceryl ether phosphorylcholine (platelet-activating factor).
Topics: Animals; Basophils; Blood Platelets; Humans; Hypersensitivity; Inflammation; Lysophosphatidylcholines; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1981 |
Release of platelet-activating factor from HL-60 human leukemic cells following macrophage-like differentiation.
Topics: Cell Line; Cell Transformation, Neoplastic; Humans; Leukemia, Myeloid, Acute; Leukocytes; Lysophosphatidylcholines; Macrophages; Platelet Activating Factor; Receptors, Complement; Tetradecanoylphorbol Acetate | 1982 |
A platelet stimulating fraction in human and animal tissues.
Topics: Animals; Blood Platelets; Chromatography, Gel; Chromatography, Thin Layer; Humans; Lysophosphatidylcholines; Platelet Activating Factor; Rabbits; Rats; Swine; Tissue Extracts; von Willebrand Diseases | 1980 |
Anaphylactic actions of platelet-activating factor.
Topics: Anaphylatoxins; Anaphylaxis; Animals; Blood Coagulation Factors; Capillary Permeability; Complement C3; Complement C3a; Complement C5; Complement C5a; Guinea Pigs; Ileum; Lung; Lysophosphatidylcholines; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor; Receptors, Complement | 1981 |
The binding of rabbit basophil-derived platelet-activating factor to rabbit platelets.
Topics: Animals; Basophils; Blood Coagulation Factors; Blood Platelets; Calcium; Carrier Proteins; Cell Membrane; Erythrocytes; In Vitro Techniques; Lymphocytes; Lysophosphatidylcholines; Peptide Hydrolases; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Protein Binding; Rabbits; Serum Albumin; Temperature | 1980 |
Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives.
Topics: Animals; Aspirin; Blood Platelets; Bronchial Spasm; Epoprostenol; In Vitro Techniques; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Prostaglandins; Rabbits; Thromboxane A2; Time Factors | 1980 |
Effect of platelet-activating factor (PAF) on human platelets.
Topics: Animals; Antimycin A; Aspirin; Blood Platelets; Cattle; Creatine Kinase; Deoxyglucose; Epoprostenol; Humans; Indomethacin; Lysophosphatidylcholines; Phosphocreatine; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Serotonin | 1982 |
Effect of synthetic PAF-acether on human neutrophil function.
Topics: Animals; Chemotactic Factors; Chemotaxis, Leukocyte; Complement System Proteins; Glucuronidase; Guinea Pigs; Humans; In Vitro Techniques; Interleukin-8; Lysophosphatidylcholines; Neutrophils; Platelet Activating Factor | 1981 |
Neutropenia induced by platelet-activating factor (PAF-acether) released from neutrophils: the inhibitory effect of prostacyclin (PGI2).
Topics: Agranulocytosis; Animals; Cell Aggregation; Epoprostenol; Humans; In Vitro Techniques; Lysophosphatidylcholines; Neutropenia; Neutrophils; Platelet Activating Factor; Prostaglandins; Rabbits | 1981 |
Potent hypotensive activity of 1-O-hexadecyl-2-O-acetyl-SN-glycero-3-phosphocholine in spontaneously hypertensive rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dinoprostone; Dose-Response Relationship, Drug; Epoprostenol; Hypertension; Kinetics; Lysophosphatidylcholines; Male; Platelet Activating Factor; Prostaglandins E; Rats; Rats, Inbred Strains | 1982 |
Platelet-activating factor stimulates the phosphatidylinositol cycle. Appearance of phosphatidic acid is associated with the release of serotonin in horse platelets.
Topics: Animals; Arachidonic Acids; Blood Platelets; Epoprostenol; Horses; Kinetics; Lysophosphatidylcholines; Phosphatidic Acids; Phosphatidylinositols; Platelet Activating Factor; Serotonin; Trifluoperazine | 1982 |
An in vivo model for studying platelet aggregation and disaggregation.
Topics: Abdomen; Acetylcholine; Adenosine Diphosphate; Animals; Blood Platelets; Collagen; Dogs; Dose-Response Relationship, Drug; Epoprostenol; Guinea Pigs; Indium; Lysophosphatidylcholines; Male; Models, Biological; Platelet Activating Factor; Platelet Aggregation; Radioisotopes; Rats; Rats, Inbred Lew; Thorax | 1982 |
Is platelet-activating factor (PAF-acether) synthesis by murine peritoneal cells (PC) a two-step process?
Topics: Acetophenones; Acetyl Coenzyme A; Acetyltransferases; Animals; Ascitic Fluid; In Vitro Techniques; Lysophosphatidylcholines; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rats | 1981 |
Platelet-activating factor (PAF) in experimentally-induced rabbit acute serum sickness: role of basophil-derived PAF in immune complex deposition.
Topics: Acute Disease; Animals; Antigen-Antibody Complex; Basophils; Cattle; Cytoplasmic Granules; Kidney; Kidney Glomerulus; Kinetics; Leukocyte Count; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Count; Proteinuria; Rabbits; Serum Albumin, Bovine; Serum Sickness | 1982 |
Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages.
Topics: Acetyltransferases; Animals; Blood Coagulation Factors; Calcium; Cell Adhesion; Kinetics; Lysophosphatidylcholines; Macrophages; Magnesium; Mice; Mice, Inbred C57BL; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Inbred Strains | 1982 |
Immature megakaryocytes in the mouse: physical characteristics, cell cycle status, and in vitro responsiveness to thrombopoietic stimulatory factor.
Topics: Acetylcholinesterase; Animals; Bone Marrow Cells; Cell Cycle; Cell Differentiation; Cell Nucleus; Cell Separation; Cell Survival; Hydroxyurea; Lysophosphatidylcholines; Megakaryocytes; Mice; Mice, Inbred C57BL; Platelet Activating Factor | 1982 |
Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues.
Topics: Animals; Blood Platelets; Capillary Permeability; Dose-Response Relationship, Drug; Female; Guinea Pigs; Histamine; Lysophosphatidylcholines; Male; Platelet Activating Factor; Rabbits; Rats; Rats, Inbred Strains; Skin Tests; Vasoconstriction | 1982 |
Blood vessels and the new mediators of inflammation.
Topics: Animals; Blood Platelets; Blood Vessels; Capillary Permeability; Humans; Inflammation; Lysophosphatidylcholines; Platelet Activating Factor; Rabbits | 1982 |
Species specificity of the platelet responses to 1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine.
Topics: Anesthesia; Animals; Blood Coagulation; Blood Platelets; Calcium Chloride; Cats; Dogs; Ether; Guinea Pigs; Heart Rate; Horses; Humans; Hypotension; Lysophosphatidylcholines; Male; Mice; Mice, Inbred Strains; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Rats, Inbred Strains; Serotonin; Species Specificity; Thrombocytopenia | 1982 |
Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
Topics: Animals; Dose-Response Relationship, Drug; Female; Lysophosphatidylcholines; Male; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1982 |
Platelet activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine). Activity of analogs lacking oxygen at the 2-position.
Topics: Animals; Blood Platelets; Chemical Phenomena; Chemistry; Glycerylphosphorylcholine; Humans; Lysophosphatidylcholines; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Rabbits; Structure-Activity Relationship | 1982 |
Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism.
Topics: Animals; Cardiac Output; Coronary Circulation; Female; Kidney; Lysophosphatidylcholines; Male; Microspheres; Platelet Activating Factor; Rats; Rats, Inbred Strains; Regional Blood Flow; Spleen; Vascular Resistance | 1982 |
Biosynthesis of platelet-activating factor (PAF)acether). III. Formation of PAF-acether from synthetic substrates by stimulated murine macrophages.
Topics: Acetyl Coenzyme A; Acyl Coenzyme A; Animals; Ascitic Fluid; Lysophosphatidylcholines; Macrophage Activation; Macrophages; Malonyl Coenzyme A; Mice; Palmitoyl Coenzyme A; Platelet Activating Factor; Rabbits; Rats; Rats, Inbred Strains; Zymosan | 1982 |
Ether lipid content and fatty acid distribution in rabbit polymorphonuclear neutrophil phospholipids.
Topics: Animals; Fatty Acids; Lysophosphatidylcholines; Mass Spectrometry; Neutrophils; Phosphatidylcholines; Phosphatidylethanolamines; Phospholipids; Platelet Activating Factor; Rabbits | 1982 |
Platelet activation in asthma.
Topics: Asthma; Humans; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation | 1982 |
The release of platelet-activating factor during phagocytosis by polymorphonuclear neutrophils and monocytes.
Topics: Blood Coagulation Factors; Humans; Kinetics; Lysophosphatidylcholines; Monocytes; Neutrophils; Phagocytosis; Platelet Activating Factor; Platelet Aggregation | 1982 |
Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin.
Topics: Acetylcholine; Animals; Aspirin; Blood Platelets; Female; Guinea Pigs; Histamine; In Vitro Techniques; Lysophosphatidylcholines; Male; Methysergide; Muscle Relaxation; Phenoxybenzamine; Platelet Activating Factor; Propranolol; Serotonin; Trachea | 1982 |
Induction of leukocytic infiltrates in rabbit skin by acetyl glyceryl ether phosphorylcholine.
Topics: Animals; Chemotaxis, Leukocyte; Dermatitis, Atopic; Female; Injections, Intradermal; Lysophosphatidylcholines; Male; Neutrophils; Platelet Activating Factor; Rabbits; Skin; Time Factors | 1982 |
Human platelet stimulation by acetyl glyceryl ether phosphorylcholine.
Topics: Blood Coagulation Factors; Blood Platelets; Dose-Response Relationship, Drug; Humans; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Platelet Factor 4; Serotonin; Time Factors | 1981 |
Thrombin-induced formation of a polar lipid material within platelets that possesses platelet-activating activity.
Topics: Adenosine Diphosphate; Animals; Apyrase; Arachidonic Acids; Blood Platelets; Cattle; Indomethacin; Lipids; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thrombin | 1980 |
Activation of rabbit platelet phospholipase and thromboxane synthesis by 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet activating factor).
Topics: Animals; Arachidonic Acids; Blood Platelets; Dose-Response Relationship, Drug; Glycerides; Kinetics; Lysophosphatidylcholines; Phospholipases; Phospholipids; Platelet Activating Factor; Rabbits; Serotonin; Thromboxane B2; Thromboxanes | 1981 |
Modification of the polar head group of acetyl glyceryl ether phosphorylcholine and subsequent effects upon platelet activation.
Topics: Animals; Blood Platelets; Kinetics; Lysophosphatidylcholines; Platelet Activating Factor; Rabbits; Serotonin; Structure-Activity Relationship | 1981 |
1-O-Alkyl-sn-glyceryl-3-phosphorylcholines: a novel class of neutrophil stimulants.
Topics: Animals; Blood Platelets; Cytochalasin B; Glucuronidase; Glycerylphosphorylcholine; Humans; Lysophosphatidylcholines; Muramidase; Neutrophils; Platelet Activating Factor; Rabbits | 1981 |
Potent platelet stimulating activity of enantiomers of acetyl glyceryl ether phosphorylcholine and its methoxy analogues.
Topics: Animals; Blood Platelets; In Vitro Techniques; Lysophosphatidylcholines; Platelet Activating Factor; Rabbits; Serotonin; Stereoisomerism; Structure-Activity Relationship | 1981 |
The presence of platelet-activating factor (PAF) in normal human mixed saliva.
Topics: Adenosine Diphosphate; Adult; Animals; Arachidonic Acids; Creatine Kinase; Dose-Response Relationship, Immunologic; Female; Hirudins; Humans; Indomethacin; Lysophosphatidylcholines; Male; Middle Aged; Platelet Activating Factor; Rabbits; Saliva; Serotonin; Thrombin | 1981 |
Platelet activating factor: an inhibitor of neutrophil activation?
Topics: Animals; Blood Coagulation Factors; Blood Platelets; Cell Aggregation; Humans; Lysophosphatidylcholines; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Rabbits; Serotonin | 1981 |
Platelet-tissue interaction: role of platelet-activating factor (PAF-acether).
Topics: Anaphylaxis; Animals; Antigen-Antibody Complex; Blood Platelets; Bronchi; Capillary Permeability; Inflammation; Lysophosphatidylcholines; Macrophages; Mice; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1980 |
Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine.
Topics: Animals; Blood Coagulation Factors; Guinea Pigs; Histamine; Ileum; Kinetics; Lysophosphatidylcholines; Muscle Contraction; Muscle, Smooth; Platelet Activating Factor | 1981 |
Intravascular pathobiology of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF). I. Intravenous infusion in guinea pigs.
Topics: Anaphylaxis; Animals; Dose-Response Relationship, Drug; Female; Guinea Pigs; Infusions, Parenteral; Leukocyte Count; Leukopenia; Lysophosphatidylcholines; Male; Papio; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Rabbits; Thrombocytopenia | 1981 |
Differential effects of platelet depletion on the physiologic alterations of IgE anaphylaxis and acetyl glyceryl ether phosphorylcholine infusion in the rabbit.
Topics: Anaphylaxis; Animals; Antigens; Blood Coagulation Factors; Blood Platelets; Blood Pressure; Female; Goats; Heart Rate; Horseradish Peroxidase; Immune Sera; Immunoglobulin E; Lung Compliance; Lysophosphatidylcholines; Male; Platelet Activating Factor; Rabbits; Respiration | 1981 |
Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils.
Topics: Animals; Blood Platelets; Glucuronidase; Humans; In Vitro Techniques; Lysophosphatidylcholines; Neutrophils; Platelet Activating Factor; Rabbits; Serotonin; Stereoisomerism; Structure-Activity Relationship | 1981 |
Neutrophil responses to platelet-activating factor.
Topics: Animals; Glucuronidase; Humans; In Vitro Techniques; Lysophosphatidylcholines; Muramidase; Neutropenia; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1981 |
Acetyl glyceryl ether phosphorylcholine. Intravascular alterations following intravenous infusion into the baboon.
Topics: Animals; Blood Cell Count; Blood Coagulation Factors; Blood Proteins; Hematocrit; Infusions, Parenteral; Lysophosphatidylcholines; Neutropenia; Papio; Platelet Activating Factor; Platelet Factor 4; Species Specificity; Thrombocytopenia; Thromboxane B2; Thromboxanes | 1981 |
In vivo metabolism of a new class of biologically active phospholipids: 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine, a platelet activating-hypotensive phospholipid.
Topics: Animals; Antihypertensive Agents; Kinetics; Lysophosphatidylcholines; Male; Platelet Activating Factor; Rats; Tissue Distribution | 1981 |
Influence of alkyl ether chain length of acetyl glyceryl ether phosphorylcholine and its ethanolamine analog on biological activity toward rabbit platelets.
Topics: Animals; Blood Platelets; Cattle; Chemical Phenomena; Chemistry; Chromatography, Thin Layer; Gas Chromatography-Mass Spectrometry; Lysophosphatidylcholines; Phosphatidylethanolamines; Phospholipid Ethers; Platelet Activating Factor; Rabbits; Serotonin; Structure-Activity Relationship | 1981 |
Inhibition of phospholipid methyltransferase during zymosan induced secretion of platelet-activating factor in human polymorphonuclear leukocytes.
Topics: Glucuronidase; Humans; In Vitro Techniques; Lysophosphatidylcholines; Methyltransferases; Neutrophils; Phagocytosis; Phosphatidyl-N-Methylethanolamine N-Methyltransferase; Phosphatidylethanolamine N-Methyltransferase; Phospholipids; Platelet Activating Factor; Zymosan | 1981 |
New total synthesis and high resolution 1H NMR spectrum of platelet-activating factor, its enantiomer and racemic mixtures.
Topics: Animals; Blood Coagulation Factors; Lysophosphatidylcholines; Magnetic Resonance Spectroscopy; Platelet Activating Factor; Platelet Aggregation; Rabbits; Stereoisomerism | 1981 |
Acetyl glyceryl ether phosphorylcholine: platelet-activating factor.
Topics: Anaphylaxis; Animals; Basophils; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Dose-Response Relationship, Immunologic; In Vitro Techniques; Lysophosphatidylcholines; Phosphorylcholine; Platelet Activating Factor; Rabbits | 1981 |
Saturated and unsaturated 1-O-alkyl-2-O-acetoyl-sn-glycero-3-phosphocholines derived from ratfish liver oil: effect on human leukocyte migration.
Topics: Animals; Cell Movement; Chemotaxis; Humans; Liver; Lysophosphatidylcholines; Neutrophils; Oils; Phosphatidylcholines; Platelet Activating Factor; Structure-Activity Relationship | 1981 |
Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes I. Analysis of the in vitro migration of human neutrophils.
Topics: Cell Movement; Chemotaxis; Humans; Kinetics; Lysophosphatidylcholines; Neutrophils; Platelet Activating Factor | 1981 |
Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Drug Interactions; Edema; Inflammation; Lysophosphatidylcholines; Pain; Platelet Activating Factor; Prostaglandins; Rats; Time Factors | 1981 |
Bronchoconstriction induced by intratracheal administration of platelet-activating factor (PAF-acether) in baboons.
Topics: Airway Resistance; Animals; Bronchi; Lung; Lung Compliance; Lysophosphatidylcholines; Muscle Contraction; Muscle, Smooth; Papio; Platelet Activating Factor; Platelet Count | 1981 |
Physical and chemical properties of platelet-activating factor obtained from human neutrophils and monocytes and rabbit neutrophils and basophils.
Topics: Animals; Basophils; Blood Platelets; Chromatography, Thin Layer; Humans; Lysophosphatidylcholines; Monocytes; Neutrophils; Platelet Activating Factor; Rabbits | 1980 |
[Do you know PAF?].
Topics: Animals; Humans; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation | 1980 |
Preliminary studies of an acid-labile factor (ALF) in human sera that inactivates platelet-activating factor (PAF).
Topics: Adult; Animals; Blood Platelets; Blood Proteins; Female; Humans; Lysophosphatidylcholines; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1980 |
Pathobiology of the intravenous infusion of acetyl glyceryl ether phosphorylcholine (AGEPC), a synthetic platelet-activating factor (PAF), in the rabbit.
Topics: Animals; Basophils; Blood Platelets; Dose-Response Relationship, Drug; Female; Infusions, Parenteral; Leukocyte Count; Lysophosphatidylcholines; Male; Neutropenia; Neutrophils; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Platelet Factor 4; Rabbits; Thrombocytopenia | 1980 |
Platelet-activating factor.
Topics: Blood Platelets; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Aggregation | 1980 |
Identification of platelet activating factor isolated from rabbit basophils as acetyl glyceryl ether phosphorylcholine.
Topics: Animals; Basophils; Chromatography, Gas; Immunoglobulin E; Lysophosphatidylcholines; Mass Spectrometry; Platelet Activating Factor; Rabbits | 1980 |
Platelet activating factor (PAF-acether): total synthesis of 1-O-octadecyl 2-O-acetyl sn-glycero-3-phosphoryl choline.
Topics: Indicators and Reagents; Lysophosphatidylcholines; Magnetic Resonance Spectroscopy; Methods; Platelet Activating Factor; Spectrophotometry, Infrared | 1980 |
Biosynthetic labelling of platelet activating factor from radioactive acetate by stimulated platelets.
Topics: Acetates; Animals; Blood Platelets; Lysophosphatidylcholines; Phospholipases; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1981 |
Respiratory and circulatory alterations induced by acetyl glyceryl ether phosphorylcholine, a mediator of IgE anaphylaxis in the rabbit.
Topics: Anaphylaxis; Animals; Blood Pressure; Female; Heart; Heart Rate; Lung; Lung Compliance; Lysophosphatidylcholines; Male; Platelet Activating Factor; Rabbits; Respiration; Vascular Resistance | 1980 |
Effects of phospholipids on renal function.
Topics: Angiotensin II; Animals; Arginine; Diuresis; Dogs; Hemodynamics; Kidney; Lysophosphatidylcholines; Natriuresis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Platelet Activating Factor; Rats; Renal Artery; Renal Circulation; Structure-Activity Relationship; Vasodilation; Vasopressins | 1993 |
Coenzyme A-independent transacylation in amnion-derived (WISH) cells.
Topics: Acylation; Acyltransferases; Amnion; Arachidonic Acid; Cell Line; Coenzyme A; Humans; Lysophosphatidylcholines; Platelet Activating Factor; Substrate Specificity | 1994 |
Isolation and characterization of seven lyso platelet-activating factors and two lyso phosphatidylcholines from the crude drug "suitetsu" (the leech, Hirudo nipponica).
Topics: Animals; Chromatography, Thin Layer; Leeches; Lysophosphatidylcholines; Magnetic Resonance Spectroscopy; Platelet Activating Factor | 1993 |
Distribution of lysophospholipids and metabolism of platelet-activating factor in human follicular and peritoneal fluids.
Topics: Albumins; Ascitic Fluid; Body Fluids; Female; Follicular Fluid; Half-Life; Humans; Hydrolysis; Lysophosphatidylcholines; Lysophospholipids; Platelet Activating Factor; Proteins; Ultracentrifugation | 1993 |
Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta.
Topics: Animals; Aorta; Arteriosclerosis; Endothelium, Vascular; Lipoproteins, LDL; Lysophosphatidylcholines; Lysophospholipase; Male; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rabbits; Sphingosine; Vasodilation | 1993 |
Reversible and irreversible inactivation of preformed pulmonary surfactant surface films by changes in subphase constituents.
Topics: Animals; Bicarbonates; Borates; Calcium Chloride; Cattle; Hydrogen-Ion Concentration; Lysophosphatidylcholines; Platelet Activating Factor; Pulmonary Surfactants; Surface Properties | 1993 |
Immunoregulatory functions of paf-acether. IX. Modulation of apoptosis in an immature T cell line.
Topics: Apoptosis; Calcimycin; Cell Line; DNA; Humans; Kinetics; Lysophosphatidylcholines; Platelet Activating Factor; T-Lymphocytes | 1993 |
Effect of lysoplatelet-activating factor on human sperm fertilizing ability.
Topics: Acrosome; Animals; Cricetinae; Female; Fertilization in Vitro; Humans; Lysophosphatidylcholines; Male; Mesocricetus; Platelet Activating Factor; Sperm Motility; Sperm-Ovum Interactions | 1993 |
Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
Topics: Administration, Inhalation; Aerosols; Airway Resistance; Animals; Azepines; Blood Pressure; Bronchoconstriction; Capillary Permeability; Dose-Response Relationship, Drug; Evans Blue; Female; Guinea Pigs; Injections, Intravenous; Lysophosphatidylcholines; Platelet Activating Factor; Respiratory Function Tests; Respiratory System; Triazoles | 1993 |
Effect of platelet-activating factor, lyso-platelet-activating factor, and lysophosphatidylcholine on sperm motion: importance of albumin for motility stimulation.
Topics: Fertilization; Humans; Infertility, Male; Lysophosphatidylcholines; Male; Osmolar Concentration; Platelet Activating Factor; Serum Albumin; Sperm Motility; Spermatozoa; Time Factors | 1993 |
Platelet activating factor and lyso-phosphatidylcholines from strawberry.
Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Fruit; In Vitro Techniques; Lysophosphatidylcholines; Phospholipid Ethers; Plant Leaves; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pollen; Rabbits; Spectrometry, Mass, Fast Atom Bombardment | 1996 |
A simple chemical synthesis of the ether analog of lysophosphatidylcholine and platelet-activating factor.
Topics: Animals; Blood Platelets; Hydrolysis; Lysophosphatidylcholines; Molecular Structure; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Rabbits; Serotonin | 1995 |
Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils.
Topics: Acridines; Adenosine Triphosphate; Antioxidants; Calcium; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Luminescent Measurements; Lysophosphatidylcholines; Neutrophil Activation; Neutrophils; Platelet Activating Factor; Propranolol | 1996 |
Lysophosphatidylcholine stimulates interleukin-6 release from rat anterior pituitary cells in vitro.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Animals; Benzophenanthridines; Cells, Cultured; Enzyme Inhibitors; Interleukin-1; Interleukin-6; Lysophosphatidylcholines; Male; Phenanthridines; Phosphorylcholine; Pituitary Gland, Anterior; Platelet Activating Factor; Prolactin; Protein Kinase C; Rats; Rats, Inbred Strains; Sphingosine | 1996 |
Determination of 1-O-acyl-2-acetyl-sn-glyceryl-3-phosphorylcholine, platelet-activating factor and related phospholipids in biological samples by high-performance liquid chromatography--tandem mass spectrometry.
Topics: Cells, Cultured; Chromatography, High Pressure Liquid; Endothelium, Vascular; Humans; Linear Models; Lysophosphatidylcholines; Mass Spectrometry; Phospholipid Ethers; Phospholipids; Platelet Activating Factor; Reference Standards; Umbilical Veins | 1996 |
Structural differences in the ability of lysophospholipids to inhibit endothelium-dependent hyperpolarization by acetylcholine in rat mesenteric arteries.
Topics: Acetylcholine; Animals; Endothelium, Vascular; In Vitro Techniques; Inflammation Mediators; Lysophosphatidylcholines; Lysophospholipids; Male; Membrane Potentials; Mesenteric Artery, Superior; Molecular Structure; Muscle, Smooth, Vascular; Phosphatidylcholines; Platelet Activating Factor; Rats; Rats, Wistar; Structure-Activity Relationship | 1996 |
Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils.
Topics: Adult; Anti-Asthmatic Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Asthma; Azithromycin; Calcimycin; Cell Membrane; Clarithromycin; Erythromycin; Humans; Ionophores; Luminescent Measurements; Lysophosphatidylcholines; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Respiratory Burst; Roxithromycin; Superoxides; Tetradecanoylphorbol Acetate; Zymosan | 1996 |
Analysis of human lecithin-cholesterol acyltransferase activity by carboxyl-terminal truncation.
Topics: Amino Acid Sequence; Animals; Binding Sites; Butyrates; COS Cells; Genetic Vectors; Glycosylation; Humans; Lipoproteins, HDL; Lipoproteins, LDL; Lysophosphatidylcholines; Micelles; Molecular Sequence Data; Phosphatidylcholine-Sterol O-Acyltransferase; Platelet Activating Factor; Proteolipids; Sequence Deletion; Solubility; Transfection | 1997 |
Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins.
Topics: Adenosine Diphosphate; Blood Platelets; Calcium; Hemofiltration; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Structure-Activity Relationship; Thrombin | 1997 |
Lipoprotein-like phospholipid particles inhibit the smooth muscle cell cytotoxicity of lysophosphatidylcholine and platelet-activating factor.
Topics: Apolipoprotein A-I; Apoptosis; Carbon Radioisotopes; Cell Count; Cell Survival; Cells, Cultured; Cytotoxins; Dose-Response Relationship, Drug; Humans; Hydroxycholesterols; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Phospholipids; Platelet Activating Factor | 1998 |
Substrate specificities of neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor: differences in the use of 1-alkyl and 1-acyl lysophospholipid acceptors.
Topics: Acetylation; Acetyltransferases; Acyl Coenzyme A; Animals; Brain; Cell Nucleus; Glycerophosphates; Kinetics; Lysophosphatidylcholines; Lysophospholipids; Neurons; Nuclear Envelope; Nuclear Proteins; Oleic Acid; Platelet Activating Factor; Rabbits; Substrate Specificity | 1998 |
MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities.
Topics: Acetyl Coenzyme A; Acetylation; Acetyltransferases; Adenosine Triphosphate; Animals; Cell Nucleus; Enzyme Inhibitors; Lysophosphatidylcholines; Neurons; Platelet Activating Factor; Protein Kinase Inhibitors; Rabbits | 1998 |
Substrate specificity of lysophospholipase D which produces bioactive lysophosphatidic acids in rat plasma.
Topics: Animals; Isomerism; Lysophosphatidylcholines; Lysophospholipids; Male; Mass Spectrometry; Phosphatidylcholines; Phosphoric Diester Hydrolases; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Rats, Wistar; Substrate Specificity | 1999 |
Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism.
Topics: Cells, Cultured; Cytokines; Humans; Interferon-gamma; Lipoproteins, LDL; Lysophosphatidylcholines; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Tumor Necrosis Factor-alpha | 1999 |
Calcium-dependent PAF-stimulated generation of reactive oxygen species in a human keratinocyte cell line.
Topics: Aniline Compounds; Calcium; Cell Line; Dose-Response Relationship, Drug; Flow Cytometry; Fluorescence; Humans; Keratinocytes; Luminescent Measurements; Lysophosphatidylcholines; Onium Compounds; Platelet Activating Factor; Platelet Membrane Glycoproteins; Potassium Cyanide; Reactive Oxygen Species; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Temperature; Xanthenes | 1999 |
Role of lecithin-cholesterol acyltransferase in the metabolism of oxidized phospholipids in plasma: studies with platelet-activating factor-acetyl hydrolase-deficient plasma.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aryldialkylphosphatase; Diglycerides; Esterases; Humans; Isoflurophate; Lipoproteins, LDL; Lysophosphatidylcholines; Oxidation-Reduction; Phosphatidylcholine-Sterol O-Acyltransferase; Phosphatidylcholines; Phospholipases A; Phospholipids; Platelet Activating Factor; Sulfones | 1999 |
Lysophospholipids trigger calcium signals but not DNA synthesis in cortical astrocytes.
Topics: Animals; Astrocytes; Calcium Signaling; Cells, Cultured; Cerebral Cortex; DNA; Lysophosphatidylcholines; Lysophospholipids; Platelet Activating Factor; Rats; Sphingomyelins | 1999 |
Lyso-PAF analogues and lysophosphatidylcholines from the marine sponge Spirastrella abata as inhibitors of cholesterol biosynthesis.
Topics: Animals; Anticholesteremic Agents; Cell Line; Cells, Cultured; Cholesterol; Depression, Chemical; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lanosterol; Liver; Lovastatin; Lysophosphatidylcholines; Magnetic Resonance Spectroscopy; Platelet Activating Factor; Porifera | 1999 |
Lipid mediators stimulate reactive oxygen species formation in immortalized human keratinocytes.
Topics: Calcium; Cell Line; Ceramides; Diterpenes; Ginkgolides; Humans; Keratinocytes; Lactones; Lipid Metabolism; Lipids; Luminescent Measurements; Lysophosphatidylcholines; Membrane Lipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pyridinium Compounds; Reactive Oxygen Species; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction | 1999 |
Characterization of the physicochemical properties of the micelles of platelet-activating factor (C18:0).
Topics: Anilino Naphthalenesulfonates; Fluorescent Dyes; Lysophosphatidylcholines; Methanol; Micelles; Oxazines; Platelet Activating Factor | 2000 |
Two-dimensional analysis of phospholipids by capillary liquid chromatography/electrospray ionization mass spectrometry.
Topics: Animals; Cell Line; Chromatography, Liquid; Lysophosphatidylcholines; Mass Spectrometry; Mice; Phosphatidylcholines; Phosphatidylethanolamines; Phosphatidylinositols; Phospholipids; Platelet Activating Factor; Reference Standards; Sphingomyelins | 2000 |
Blood transfusion and the two-insult model of post-injury multiple organ failure.
Topics: Blood Preservation; Cell Adhesion; Cells, Cultured; Chemotaxis, Leukocyte; Drug Synergism; Endothelium, Vascular; Fibrinogen; Humans; Inflammation; Lysophosphatidylcholines; Models, Biological; Multiple Organ Failure; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidative Stress; Platelet Activating Factor; Risk; Superoxides; Transfusion Reaction | 2001 |
Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity.
Topics: Arteriosclerosis; DNA; Down-Regulation; Humans; Lipopolysaccharides; Lipoproteins, LDL; Lysophosphatidylcholines; Macrophages; Monocytes; NF-kappa B; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 2001 |
Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro.
Topics: Cells, Cultured; Humans; Lysophosphatidylcholines; Mucociliary Clearance; Nasal Mucosa; Phospholipids; Platelet Activating Factor; Vitamin E | 2001 |
Lysophosphatidylcholine and lyso-PAF display PAF-like activity derived from contaminating phospholipids.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Calcium; Drug Contamination; Fluorescence; Humans; Hydrolysis; Inflammation; Lysophosphatidylcholines; Mice; Phospholipases A; Phospholipids; Platelet Activating Factor; Platelet Membrane Glycoproteins; Pleurisy; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Recombinant Proteins; Transfection | 2001 |
Plasmodium falciparum phospholipase C hydrolyzing sphingomyelin and lysocholinephospholipids is a possible target for malaria chemotherapy.
Topics: Amides; Amino Acid Sequence; Animals; Genes, Protozoan; Lysophosphatidylcholines; Molecular Sequence Data; Plasmodium falciparum; Platelet Activating Factor; Pyrones; Recombinant Proteins; Sequence Homology, Amino Acid; Sphingomyelin Phosphodiesterase; Sphingomyelins; Substrate Specificity; Type C Phospholipases | 2002 |
Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro.
Topics: Anti-Bacterial Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Inflammation Mediators; Lysophosphatidylcholines; Platelet Activating Factor; Potassium; Rubidium | 2002 |
Clinically relevant hypertonicity prevents stored blood- and lipid-mediated delayed neutrophil apoptosis independent of p38 MAPK or caspase-3 activation.
Topics: Apoptosis; Blood Preservation; Caspase 3; Caspase Inhibitors; Caspases; Enzyme Activation; Enzyme Inhibitors; Humans; Imidazoles; In Vitro Techniques; Lysophosphatidylcholines; Mitogen-Activated Protein Kinases; Multiple Organ Failure; Neutrophils; Oligopeptides; p38 Mitogen-Activated Protein Kinases; Platelet Activating Factor; Pyridines; Saline Solution, Hypertonic | 2003 |
Antibodies against platelet-activating factor and platelet-activating factor-like lipids are raised in women with primary recurrent abortion.
Topics: Abortion, Habitual; Adult; Antibodies; Cardiolipins; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; Oxidation-Reduction; Phosphatidylcholines; Platelet Activating Factor; Pregnancy | 2003 |
Temporary membrane distortion of vascular smooth muscle cells is responsible for their apoptosis induced by platelet-activating factor-like oxidized phospholipids and their degradation product, lysophosphatidylcholine.
Topics: alpha-Tocopherol; Animals; Aorta; Apoptosis; Cell Membrane; Cell Membrane Permeability; Cell Size; Cholesterol; Lipoproteins, LDL; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Oxidation-Reduction; Phospholipids; Platelet Activating Factor; Rats | 2003 |
Chromogenic assay for the activity of sphingomyelinase from Bacillus cereus and its application to the enzymatic hydrolysis of lysophospholipids.
Topics: Bacillus cereus; Hydrolysis; Kinetics; Lysophosphatidylcholines; Lysophospholipids; Octoxynol; Phosphorylcholine; Platelet Activating Factor; Sphingomyelin Phosphodiesterase; Time Factors | 2004 |
An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry.
Topics: Catalysis; Chromatography; Chromatography, High Pressure Liquid; Clinical Chemistry Tests; Glycerophospholipids; Humans; Lipid Metabolism; Lipids; Lysophosphatidylcholines; Mass Spectrometry; Neutrophils; Platelet Activating Factor; Sensitivity and Specificity; Time Factors | 2005 |
Lysophosphatidylcholine modulates neutrophil oxidant production through elevation of cyclic AMP.
Topics: Animals; Capillary Permeability; CD11b Antigen; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Extracellular Signal-Regulated MAP Kinases; Humans; In Vitro Techniques; Lung; Lysophosphatidylcholines; Mice; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophil Activation; Neutrophils; Oxidants; Phosphoproteins; Platelet Activating Factor; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Superoxides; Tetradecanoylphorbol Acetate; Up-Regulation | 2005 |
Human resting CD16-, CD16+ and IL-2-, IL-12-, IL-15- or IFN-alpha-activated natural killer cells differentially respond to sphingosylphosphorylcholine, lysophosphatidylcholine and platelet-activating factor.
Topics: Cell Cycle Proteins; Chemotaxis; Diterpenes; Fibrinolytic Agents; Flow Cytometry; Ginkgolides; Humans; Interferon-alpha; Interleukins; Killer Cells, Natural; Lactones; Lymphocyte Activation; Lysophosphatidylcholines; Pertussis Toxin; Phosphorylcholine; Platelet Activating Factor; Receptors, G-Protein-Coupled; Receptors, IgG; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sphingosine | 2005 |
Modulation of ecto-5'-nucleotidase by phospholipids in human umbilical vein endothelial cells (HUVEC).
Topics: 5'-Nucleotidase; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Endothelial Cells; Humans; Lysophosphatidylcholines; Molecular Structure; Phospholipids; Platelet Activating Factor; Sphingosine; Umbilical Veins | 2005 |
Purification and characterization of lysophospholipase D from rat brain.
Topics: Animals; Brain; Hydrogen-Ion Concentration; In Vitro Techniques; Kinetics; Lysophosphatidylcholines; Male; Molecular Weight; Phosphoric Diester Hydrolases; Platelet Activating Factor; Pyrophosphatases; Rats; Rats, Wistar; Substrate Specificity | 2006 |
Release, purification, and characterization of platelet-activating factor (PAF).
Topics: Acetophenones; Blood Platelets; Calcium; Chromatography; Edetic Acid; Humans; Hydrogen-Ion Concentration; Leukocytes; Lysophosphatidylcholines; Mass Spectrometry; Phospholipases A; Phospholipases A2; Phospholipids; Platelet Activating Factor; Silicic Acid; Temperature | 1980 |
Identification of lysophosphatidylcholine (LPC) and platelet activating factor (PAF) from PC12 cells and mouse cortex using liquid chromatography/multi-stage mass spectrometry (LC/MS3).
Topics: Animals; Cerebral Cortex; Chromatography, Liquid; Female; Lysophosphatidylcholines; Mass Spectrometry; Mice; Mice, Inbred C57BL; PC12 Cells; Platelet Activating Factor; Rats | 2008 |
A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.
Topics: 1-Acylglycerophosphocholine O-Acyltransferase; Acetyl Coenzyme A; Animals; Chlorocebus aethiops; Cloning, Molecular; COS Cells; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Disease Models, Animal; Hypoglycemic Agents; Lysophosphatidylcholines; Male; Mice; Platelet Activating Factor; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Rosiglitazone; Thiazolidinediones; Transfection | 2009 |
sPLA2-V inhibits EPCR anticoagulant and antiapoptotic properties by accommodating lysophosphatidylcholine or PAF in the hydrophobic groove.
Topics: Animals; Antigens, CD; Chromatography, Thin Layer; Endothelial Cells; Endothelial Protein C Receptor; Enzyme Activation; Flow Cytometry; Group V Phospholipases A2; Humans; Immunohistochemistry; Lysophosphatidylcholines; Mass Spectrometry; Mice; Platelet Activating Factor; Protein C; Protein Structure, Tertiary; Receptors, Cell Surface; Spectrometry, Fluorescence | 2012 |
Computational identification and experimental characterization of substrate binding determinants of nucleotide pyrophosphatase/phosphodiesterase 7.
Topics: Amino Acid Sequence; Animals; Biocatalysis; Humans; Kinetics; Lysophosphatidylcholines; Models, Molecular; Molecular Sequence Data; Platelet Activating Factor; Sequence Alignment; Sphingomyelin Phosphodiesterase; Sphingomyelins; Substrate Specificity | 2011 |
Activation of bile salt dependent lipase by (lyso)phosphatidic acid and platelet activating factor.
Topics: Binding Sites; Enzyme Activation; Enzyme Assays; Female; Humans; Kinetics; Lipase; Lysophosphatidylcholines; Lysophospholipids; Milk, Human; Phosphatidic Acids; Phosphatidylcholines; Platelet Activating Factor; Protein Binding; Taurocholic Acid | 2013 |
Quantitative determination of major platelet activating factors from human plasma.
Topics: Chromatography, Liquid; Humans; Lysophosphatidylcholines; Platelet Activating Factor; Tandem Mass Spectrometry | 2014 |
Structural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruzi.
Topics: Animals; Azepines; Lysophosphatidylcholines; Models, Molecular; Molecular Docking Simulation; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Rabbits; Receptors, G-Protein-Coupled; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Triazoles; Trypanosoma cruzi | 2014 |
Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Female; Humans; Logistic Models; Longitudinal Studies; Lysophosphatidylcholines; Male; Mass Spectrometry; Plasmalogens; Platelet Activating Factor | 2018 |
Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Azepines; Chromatography, Liquid; Female; Healthy Volunteers; Lysophosphatidylcholines; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Mice, Knockout; Phospholipids; Platelet Activating Factor; Platelet Aggregation; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Triazoles | 2018 |
Comprehensive lipidomic, metabolomic and proteomic profiling reveals the role of immune system in vitiligo.
Topics: Adult; Aspartic Acid; beta-Thromboglobulin; Case-Control Studies; Female; Glycerol; Humans; Lipidomics; Lysophosphatidylcholines; Male; Metabolome; Phosphorylcholine; Platelet Activating Factor; Platelet Factor 4; Succinic Acid; Vitiligo; Young Adult | 2019 |
Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects.
Topics: Animals; Cerebellum; Cytokines; Demyelinating Diseases; Gene Deletion; Inflammation Mediators; Lysophosphatidylcholines; Mice, Inbred C57BL; Mice, Knockout; Microglia; Myelin Basic Protein; Neurofilament Proteins; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Transcription, Genetic | 2020 |
Interaction of Native- and Oxidized-Low-Density Lipoprotein with Human Estrogen Sulfotransferase.
Topics: Animals; Atherosclerosis; Humans; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Mice; Mice, Knockout; Platelet Activating Factor; Protein Binding; Sulfotransferases | 2021 |
A novel receptor for platelet-activating factor and lysophosphatidylcholine in Trypanosoma cruzi.
Topics: Amino Acid Sequence; Animals; Cell Differentiation; Chagas Disease; Gene Knockout Techniques; Host-Parasite Interactions; Humans; Lysophosphatidylcholines; Macrophages; Mice; Molecular Docking Simulation; Phylogeny; Platelet Activating Factor; Protein Conformation; Protozoan Proteins; Receptors, Adiponectin; Receptors, Progesterone; Trypanosoma cruzi | 2021 |